Patent details

EP3142748 Title: USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS

Basic Information

Publication number:
EP3142748
PCT Application Number:
US2015030764
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157271446
PCT Publication Number:
WO2015175773
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS
French Title of Invention:
UTILISATION D'INHIBITEURS DE PDE4 ET DE LEURS COMBINAISONS POUR LE TRAITEMENT DE LA FIBROSE KYSTIQUE
German Title of Invention:
VERWENDUNG VON PDE4-INHIBITOREN UND KOMBINATIONEN DAVON ZUR BEHANDLUNG VON ZYSTISCHER FIBROSE
SPC Number:

Dates

Filing date:
14/05/2015
Grant date:
11/09/2019
EP Publication Date:
22/03/2017
PCT Publication Date:
19/11/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/09/2019
EP B1 Publication Date:
11/09/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/05/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/03/2020
 
 

Name:
Amgen (Europe) GmbH
Address:
Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)

History of Owners

From:
04/09/2019
To:
06/03/2020

Name:
Celgene Corporation
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:
SCHAFER, Peter
Address:
United States (US)

2

Name:
KORISH, Shimon
Address:
United States (US)

Priority

Priority Number:
201461993467 P
Priority Date:
15/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4035; A61K 31/443; A61K 31/47; A61K 45/06; A61P 11/00;

Publication

European Patent Bulletin

1

Issue number:
201937
Publication date:
11/09/2019
Description:
Grant (B1)

2

Issue number:
202015
Publication date:
08/04/2020
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
12
Annual Fee Amount:
165 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/04/2025
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
148 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages